Cargando…

Targeting metabolism to treat multiple sclerosis

Detalles Bibliográficos
Autor principal: Bhargava, Pavan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996022/
https://www.ncbi.nlm.nih.gov/pubmed/32985474
http://dx.doi.org/10.4103/1673-5374.293143
_version_ 1783670028449611776
author Bhargava, Pavan
author_facet Bhargava, Pavan
author_sort Bhargava, Pavan
collection PubMed
description
format Online
Article
Text
id pubmed-7996022
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-79960222021-06-02 Targeting metabolism to treat multiple sclerosis Bhargava, Pavan Neural Regen Res Perspective Wolters Kluwer - Medknow 2020-09-22 /pmc/articles/PMC7996022/ /pubmed/32985474 http://dx.doi.org/10.4103/1673-5374.293143 Text en Copyright: © 2021 Neural Regeneration Research http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Perspective
Bhargava, Pavan
Targeting metabolism to treat multiple sclerosis
title Targeting metabolism to treat multiple sclerosis
title_full Targeting metabolism to treat multiple sclerosis
title_fullStr Targeting metabolism to treat multiple sclerosis
title_full_unstemmed Targeting metabolism to treat multiple sclerosis
title_short Targeting metabolism to treat multiple sclerosis
title_sort targeting metabolism to treat multiple sclerosis
topic Perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996022/
https://www.ncbi.nlm.nih.gov/pubmed/32985474
http://dx.doi.org/10.4103/1673-5374.293143
work_keys_str_mv AT bhargavapavan targetingmetabolismtotreatmultiplesclerosis